The Prognostic Value of Treatment-Related Lymphopenia in Nasopharyngeal Carcinoma Patients

키워드

참고문헌 (32)

1. Cao SM, "The prevalence and prevention of nasopharyngeal carcinoma in China", Chin J Cancer, 30, pp.114~119 (2011)[DOI]
2. Choa G, "Nasopharyngeal carcinoma: some observations on the clinical features and technique of examination", Pac Med Surg, 75, pp.172~174 (1967)
3. Al-Sarraf M, "Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099", J Clin Oncol, 16, pp.1310~1317 (1998)[DOI]
4. Chan AT, "Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial", J Clin Oncol, 20, pp.2038~2044 (2002)[DOI]
5. Lee AW, "Factors contributing to the efficacy of concurrent-adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: combined analyses of NPC-9901 and NPC-9902 Trials", Eur J Cancer, 47, pp.656~666 (2011)[DOI]
6. Sun X, "Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities", Radiother Oncol, 110, pp.398~403 (2014)[DOI]
7. Ludwig JA, "Biomarkers in cancer staging, prognosis and treatment selection", Nat Rev Cancer, 5, pp.845~856 (2005)[DOI]
8. Wei WI, "Nasopharyngeal carcinoma", Lancet, 365, pp.2041~2054 (2005)[DOI]
9. Fogar P, "Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome", Pancreas, 32, pp.22~28 (2006)[DOI]
10. Sarraf KM, "Neutrophil", lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer, 2009, pp.137, 425~428
11. Formenti SC, "Combining radiotherapy and cancer immunotherapy: a paradigm shift", J Natl Cancer Inst, 105, pp.256~265 (2013)[DOI]
12. Santin AD, "Effects of concurrent cisplatinum administration during radiotherapy vs. radiotherapy alone on the immune function of patients with cancer of the uterine cervix", Int J Radiat Oncol Biol Phys., 48, pp.997~1006 (2000)[DOI]
13. Stratton JA, "A comparison of the acute effects of radiation therapy, including or excluding the thymus, on the lymphocyte subpopulations of cancer patients", J Clin Invest, 56, pp.88~97 (1975)[DOI]
14. Sellins KS, "Gene induction by gamma-irradiation leads to DNA fragmentation in lymphocytes", J Immunol, 139, pp.3199~3206 (1987)
15. Lissoni P, "Radiotherapy-induced lymphocytopenia: changes in total lymphocyte count and in lymphocyte subpopulations under pelvic irradiation in gynecologic neoplasms", J Biol Regul Homeost Agents, 19, pp.153~158 (2005)
16. Campian JL, "Treatment-related lymphopenia in patients with stage III non-small-cell lung cancer", Cancer Invest, 31, pp.183~188 (2013)[DOI]
17. Cho O, "Radiation-related lymphopenia as a new prognostic factor in limited-stage small cell lung cancer", Tumour Biol, 37, pp.971~978 (2016)[DOI]
18. Mehrazin R, "Lymphopenia is an independent predictor of inferior outcome in papillary renal cell carcinoma", Urol Oncol, 33, pp.388.e19~388.e25 (2015)[DOI]
19. Grossman SA, "Survival in patients with severe lymphopenia following treatment with radiation and chemotherapy for newly diagnosed solid tumors", J Natl Compr Canc Netw, 13, pp.1225~1231 (2015)[DOI]
20. Liu Y, "Establishment of VCA and EBNA1 IgA-based combination by enzyme-linked immunosorbent assay as preferred screening method for nasopharyngeal carcinoma: a two-stage design with a preliminary performance study and a mass screening in southern China", Int J Cancer, 131, pp.406~416 (2012)[DOI]
21. An X, "Plasma Epstein-Barr virus DNA level strongly predicts survival in metastatic", recurrent nasopharyngeal carcinoma treated with palliative chemotherapy, 2011, pp.117, 3750~3757
22. Shao JY, "Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A", virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma, 2004, pp.100, 1162~1170
23. Lin S, "Sequential chemotherapy and intensity-modulated radiation therapy in the management of locoregionally advanced nasopharyngeal carcinoma: experience of 370 consecutive cases", BMC Cancer, 10, pp.39~ (2010)[DOI]
24. Yovino S, "Severity, etiology and possible consequences of treatment-related lymphopenia in patients with newly diagnosed high-grade gliomas", CNS Oncol, 1, pp.149~154 (2012)[DOI]
25. Tang C, "Lymphopenia association with gross tumor volume and lung V5 and its effects on non-small cell lung cancer patient outcomes", Int J Radiat Oncol Biol Phys, 89, pp.1084~1091 (2014)[DOI]
26. Cho O, "Minimum absolute lymphocyte count during radiotherapy as a new prognostic factor for nasopharyngeal cancer", Head Neck, 38(Suppl 1), pp.E1061~E1067 (2016)[DOI]
27. Lee NY, "Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial", Lancet Oncol, 13, pp.172~180 (2012)[DOI]
28. Twu CW, "Metronomic adjuvant chemotherapy improves treatment outcome in nasopharyngeal carcinoma patients with postradiation persistently detectable plasma Epstein-Barr virus deoxyribonucleic acid", Int J Radiat Oncol Biol Phys, 89, pp.21~29 (2014)[DOI]
29. Merlo A, "Immunotherapy for EBV-associated malignancies", Int J Hematol, 93, pp.281~293 (2011)[DOI]
30. Louis CU, "Adoptive transfer of EBV-specific T cells results in sustained clinical responses in patients with locoregional nasopharyngeal carcinoma", J Immunother, 33, pp.983~990 (2010)[DOI]
31. Chia WK, "Adoptive T-cell transfer and chemotherapy in the first-line treatment of metastatic and", or locally recurrent nasopharyngeal carcinoma, 2014, pp.22, 132~139
32. Li J, "Phase I trial of adoptively transferred tumor-infiltrating lymphocyte immunotherapy following concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma", Oncoimmunology, 4, pp.e976507~ (2015)[DOI]

관련 논문AI추천